Contents: Proteomics for clinical use
Available and applied single risk marker strategies in nephrology based on hypothesis driven biomarker search
Open or unbiased multimarker approaches including plasma and urine proteomics
Examples from different renal diseases
Data from cross sectional and longitudinal studies
Proteomics may provide insight into disease pathology
Proteomics may provide risk stratification for clinical trials
Example: intervention trial for type 2 diabetic subjects with high risk urinary proteomic pattern.